Biotia is a health tech startup offering AI-based solutions to diagnose and control infectious disease.
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 10, 2019 | Seed | $2.40M | 1 | Falcon III Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Falcon III Ventures | Yes | Seed |